Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract by Zhang, Yi et al.
Genetic polymorphisms of superoxide dismutases, catalase, and
glutathione peroxidase in age-related cataract
Yi Zhang,1 Lan Zhang,2 DongLin Sun,3 ZhiSheng Li,1 Lin Wang,1 Ping Liu1
1Eye hospital, The First Affiliated Hospital, Harbin Medical University, Harbin, China; 2Cardiovascular Medicine, The Fourth
Affiliated Hospital, Harbin Medical University, Harbin, China; 3Laboratory of Medical Genetics, Harbin Medical University,
Harbin, China
Purpose: The antioxidant enzymes pathway is considered the most important pathway involved in the repair of reactive
oxygen species (ROS)–induced damage. Therefore, we investigate the possible association between polymorphisms of
Cu/Zn superoxide dismutase (SOD1), catalase (CAT), and glutathione peroxidase (GPX) genes and age -related cataract
development.
Methods: The study included 415 cataract patients (121 patients with cortical, 109 with nuclear, 59 with posterior
subcapsular, and 126 with mixed type) and 386 healthy control group of similar age. Genotyping of SOD1–251A/G, CAT–
21A/T, and GPX1–198C/T was done by polymerase chain reaction and restriction fragment length polymorphism (PCR-
RFLP) method. Differences in the frequencies were estimated using the χ2 test and risk was estimated with an unconditional
logistic regression after adjusting for age and gender.
Results:  SOD1  G/G  genotype  frequency  was  significantly  higher  in  cataract  patients  (p=0.012,  OR=1.642,  95%
CI=1.129–2.389). SOD1 A/A genotypes (p=0.001, OR=0.613, 95% CI=0.461–0.817) seem to have a protective role
against cataract, and the G allele (p=0.001, OR=1.479, 95% CI=1.208–1.810) plays a dangeous effect against in the
development of cataract. In CAT–21A/T and GPX1–198C/T polymorphisms, there were no significant differences in the
variant homozygous frequencies in patients compared to controls (p=0.226, OR=1.358, 95% CI=0.839–2.199; p=0.521,
OR=1.205, 95% CI=0.726–2.001, respectively). Stratification by the subtypes revealed that association between SOD
polymorphism and cataract was in cortical and mixed type cataract. The genotype frequency of the GG and AA of SOD1–
251A/G was significantly different in cortical and mixed type cataract group (p=0.031; OR: 1.805, 95% CI: 1.076–3.026;
p=0.002; OR: 2.229, 95% CI: 1.364–3.645; p=0.026; OR: 0.608, 95% CI: 0.396–0.933; p=0.001; OR: 0.474, 95% CI:
0.305–0.734, respectively) compared to healthy controls.
Conclusions: Results suggest that the G/G genotype of the SOD1–251A/G polymorphism may be associated with an
increased risk of cataract. However, in CAT–21A/T and GPX1–198C/T polymorphisms, there were no significant
differences in the variant homozygous frequencies in patients compared to controls.
One of the most common causes of blindness around the
world is cataract, which is a multifactorial eye disease and a
major cause of the loss of lens transparency in the aging
population [1]. Oxidative stress is a major factor that often
leads to cataract formation [2-4]. Oxidative stress is defined
as a disturbance in the balance between the production of
reactive  oxygen  species  (ROS)  and  antioxidant  defenses,
including enzymatic and non-enzymatic systems [5,6].
ROS is mostly generated within the mitochondria in lens
epithelium cells (LECs) and the superficial fiber cells, which
are highly reactive. A certain level of ROS is crucial for the
proper regulation of cell functions, such as intracellular signal,
transcription activation, cell proliferation, inflammation, and
apoptosis,  but  higher  amounts  of  ROS  are  harmful  to
macromolecules [7]. In the lens, superoxide dismutase (SOD),
catalase (CAT), and glutathione peroxidase (GPX), are some
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of the antioxidant enzymes that protect the organisms from
oxidative damage [6,8,9]. SOD decomposes superoxide into
hydrogen  peroxide.  CAT  catalyzes  the  decomposition  of
hydrogen peroxide into water and oxygen, thereby preventing
cell  damage  from  high  levels  of  ROS.  GPXs  are
selenoproteins that reduce organic peroxides and hydrogen
peroxide through the coupled oxidation of glutathione [10,
11].
Genetic variations in the antioxidant genes coding for the
SOD, CAT, and GPX enzymes may lead to decreased or
impaired regulation of their enzymatic activity and alter ROS
detoxification. Therefore, genetic variations among enzymes
that protect the cell against ROS may modulate disease risk
[12]. Due to the high interaction potentiality of ROS with
genetic  material,  polymorphisms  in  genes  coding  for
antioxidant enzymes may play an important role for inter-
individual differences in maintaining the human genome’s
integrity.  Genetic  polymorphisms  in  SOD,CAT,  and  GPX
have been implicated in proneness to cancer and other diseases
[13-15].
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2325These potentially significant genetic variants related to
oxidative  stress  have  already  been  studied  extensively,
including single nucleotide polymorphisms (SNP) –251A/G
of the SOD1 gene (NCBI, refSNP ID: rs2070424), –21A/T in
the promoter region of the CAT gene (NCBI, refSNP ID:
rs7943316), and –198C/T of the GPX1 gene (NCBI, refSNP
ID: rs1050450). SOD1–251A/G, CAT–21A/T, and GPX1–
198C/T polymorphisms are the most common and important
of antioxidant enzymes. Most of these polymorphisms result
in changes in the levels or the activities of these enzymes,
which can lead to reduced protection against oxidative stress
[12,15-19]. The effect of these variations on the lens has not
yet been clarified, so we choose these candidate SNPs to study
in our work.
The purpose of the present study was to evaluate the
possible association between these enzyme’s genes and the
risk of age-related cataract in the Chinese population. We
analyzed SOD1–251A/G, CAT–21A/T, and GPX1–198C/T
polymorphisms  in  patients  with  age-related  cataract  and
otherwise healthy age-matched individuals in a control group.
We  hypothesized  that  polymorphic  variations  in  these
antioxidant  genes  modify  the  risk  of  age-related  cataract,
especially  when  oxidative  stress  is  increased  and  non-
enzymatic antioxidants are deficient.
METHODS
Subjects: Patients with senile cataract were recruited from the
Eye Hospital, the First Affiliated Hospital, Harbin Medical
University, Harbin, China. This case-control study included a
total of 415 patients with age-related cataract and 386 disease-
free controls of Han Chinese. All 415 subjects with cataract
had  severe  visual  disturbances,  and  their  corrected  visual
acuities were under 0.3, had an age-related cataract in at least
one eye, and had no other eye abnormalities that could explain
the vision loss. Cataract status was determined by the lens
examination using a slit-lamp biomicroscope. Lens opacities
were classified into cortical, nuclear, posterior subcapsular,
and  mixed  type  using  the  Lens  Opacities  Classification
System  II  (LOCS  II)  [20].  We  excluded  patients  with
secondary  cataract  due  to  diabetes,  trauma,  steroid
administration, and other causes. The sex and age-matched
control subjects were collected from unrelated volunteers in
the same clinic. Both groups belonged to the same ethnic
group. The mean ages for the cataract patients and the controls
were 67.17±6.92 years and 65.77±6.49 years, and of them
53.0% and 52.3% were men, respectively (Table 1). Informed
consent was obtained from each subject before the study. The
study was approved by the Bioethics Committee of the Harbin
Medical  University,  China,  and  each  patient  gave  written
informed consent.
Blood samples and DNA isolation: We collected 5 ml of
venous blood into EDTA tubes from all of the patients and the
controls. Immediately after collection, all blood was stored in
aliquots at −80 °C until use. Genomic DNA was extracted
from leukocytes using a Roche DNA purification kit (Roche
Diagnostics GmbH, Mannheim, Germany) according to the
manufacturer’s instructions.
Genotyping  of  SOD1–251A/G:  SOD1  genotypes  were
detected using a multiplex PCR–RFLP method. An A→G in
exon  10  (codon  399)  was  amplified  to  form  undigested
fragments of 570 bp using primers, described in Table 2. PCR
conditions were 94 °C for 4 min, followed by 35 cycles of
TABLE 1. DEMOGRAPHIC DATA OF THE PATIENTS AND CONTROLS.
Demographic data Cataract group Control group p-value
Number of patients 415 386  
Gender     0.887
Male, n (%) 220 (53.0%) 202 (52.3%)  
Female, n (%) 195 (47.0%) 184 (47.7%)  
Age (years)     0.134
Mean±SD 67.17±6.92 65.77±6.49  
TABLE 2. PRIMERS FOR PCR AMPLIFICATION.
SOD1–251A/G primers
5′-AGTACTGTCAACCACTAGCA-3′ (forward)
5′-CCAGTGTGCGGCCAATGATG-3′ (reverse)
CAT–21A/T primers
5′-AATCAGAAGGCAGTCCTCCC-3′ (forward)
5′-TCGGGGAGCACAGAGTGTAC-3′ (reverse)
GPX–198 C/T primers
5′-TGT GCC CCT ACG GTA CA-3′ (forward)
5′-CCA AAT GAC AAT GAC ACA GG-3′ (reverse)
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232694 °C for 50 s, 63 °C for 50 s, 72 °C for 50 s, and a final
extension step at 72 °C for 7 min. The 570 bp PCR products
were digested with MspI (MBI Fermentas, Burlington, CA)
at 37 °C for 5 h and analyzed with 2% agarose gels. MspI
digestion resulted in one fragment of 570 bp for wild-type
(AA);  two  fragments  of  369  and  201  bp  for  variant
homozygous (GG); and three fragments of 570, 369, and 201
bp for heterozygous (AG).
Genotyping of CAT–21A/T: CAT genotypes were detected
using a multiplex PCR–RFLP method. An A→T in exon7
(codon 326) was amplified to form undigested fragments of
250 bp using primers, described in Table 2. PCR conditions
were 94 °C for 4 min, followed by 35 cycles of 94 °C for 25
s, 62 °C for 25 s, 72 °C for 25 s, and a final extension step at
72 °C for 7 min. The 250 bp PCR products were digested with
HInfI (MBI Fermentas) at 37 °C for 5 h and analyzed with
2.5% agarose gels. HInfI digestion resulted in two fragments
of 177 and 73 bp for wild-type (AA); three fragments of 250,
177, 73 bp for heterozygous (AT); and one fragment of 250
bp for the variant homozygous (TT).
Genotyping of GPX–198 C/T: GPX genotypes were detected
using a multiplex PCR–RFLP method. An C→T in exon 10
(codon 198) was amplified to form undigested fragments of
338 bp using primers, described in Table 2. PCR conditions
were 94 °C for 4 min, followed by 35 cycles of 94 °C for 35
s, 60 °C for 35 s, 72 °C for 35 s, and a final extension step at
72 °C for 7 min. The 338 bp PCR products were digested with
ApaI (MBI Fermentas) at 37 °C for 5 h and analyzed with 2%
agarose gels. ApaI digestion resulted in one fragment of 338
bp for variant homozygous (Leu/Leu); two fragments of 257
and 81 bp for wild-type (Pro/Pro); and three fragments of 338,
257, and 81 bp for heterozygous (Pro/Leu).
Statistical analysis: Statistical analyses were performed with
SPSS for Windows (version 17.0; SPSS Inc., Chicago, IL).
Differences  between  the  means  of  the  two  continuous
variables were evaluated by the Student’s t-test. χ2 or Fischer’s
exact  test  (two-sided)  was  used  to  compare  the  gender
distribution, test the association between the genotypes and
alleles  in  relation  to  the  cases  and  controls,  and  test  for
deviation of the genotype distribution from Hardy - Weinberg
equilibrium (HWE). The odds ratio (OR) and 95% confidence
intervals (CIs) were calculated to estimate the strength of the
association  between  polymorphism  genotype  alleles  and
patients and controls. Mean±SD are presented for continuous
variables and p values of <0.05 were considered statistically
significant.
RESULTS
There  were  no  significant  differences  for  sex,  age,  and
ethnicity,  which  suggested  that  cataract  patients'  data  are
comparable with controls (see Table 1). Three genotypes were
determined  for  all  cataract  cases  and  controls.  For  all
polymorphisms, the more common allele was considered the
reference  genotype,  whereas  the  less  common  allele  was
examined as the variant. The distributions of the SOD1-251A/
G,  CAT-21A/T,  and  GPX-198  C/T  genotypes  were  in
accordance with the Hardye Weinberg Equilibrium among the
patients (p=0.187, p=0.265, p=0.825, respectively) and the
controls  (p=0.106,  p=0.531,  p=0.746,  respectively).  The
frequencies of the genotypes and alleles of SOD1–251A/G,
CAT–21A/T, and GPX1–198C/T polymorphisms in the age-
related cataract and control groups are shown in Table 3.
As shown in Figure 1, the analysis of the polymorphisms
located at SOD1 codon 399 in the cataract group showed that
138 (33.3%) were wild-type for the A/A genotype, 86 (20.7%)
were variant homozygous for the G/G genotype, and 191
(46.0%) were heterozygous for the A/G genotype. There was
a significant difference between the case and control groups
in the SOD1 G/G genotype (p=0.012). The statistical analysis
revealed  a  possible  dangeous  effect  of  the  SOD1  G/G
genotype  (OR=1.642,  95%  CI=1.129–2.389)  in  the
development of cataract and a possible protective effect of the
A/A genotype (OR=0.613, 95% CI=0.461–0.817) in controls.
When compared to healthy controls, the allele frequency of
the G allele of SOD1–251A/G was significantly different in
the  cataract  group  (p=0.001,  OR=1.479,  95%  CI=1.208–
1.810).
However,  no  statistically  significant  differences  were
observed in the alleles or in the genotype frequencies of the
CAT–21A/T,  and  GPX1–198C/T  gene  polymorphisms
between the control group and the patients with age-related
cataract  (Table  3).  In  addition,  there  were  no  significant
differences between the case and control groups in the CAT
T/T genotype (p=0.226, OR=1.358, 95% CI=0.839–2.199).
When compared to healthy controls, the allele frequency of
the T allele of CAT–21A/T was not significantly different in
the  cataract  group  (p=0.123,  OR=1.187,  95%  CI=0.956–
1.474). There was no significant difference between the case
and  control  groups  in  the  GPX1  T/T  genotype  (p=0.521,
OR=1.205,  95%  CI=0.726–2.001).  When  compared  to
healthy  controls,  the  allele  frequency  of  the  T  allele  of
GPX1–198C/T was not significantly different in the cataract
group (p=0.135, OR=1.183, 95% CI=0.952–1.471).
Table 4 shows the distribution of genotype frequencies
of  SOD1-251A/G,  CAT-21A/T,  and  GPX-198  C/T
polymorphisms in healthy controls and cataract patients after
stratifying  by  the  cataract  subtypes.  When  compared  to
healthy  controls,  the  genotype  frequency  of  the  GG  of
SOD1-251A/G  was  significantly  different  in  cortical  and
mixed type cataract group (p=0.031; OR: 1.805, 95% CI:
1.076–3.026;  p=0.002;  OR:  2.229,  95%  CI:  1.364–3.645,
respectively),  and  the  genotype  frequency  of  the  AA  of
SOD1-251A/G  was  significantly  different  in  cortical  and
mixed type cataract group (p=0.026; OR: 0.608, 95% CI:
0.396–0.933;  p=0.001;  OR:  0.474,  95%  CI:  0.305–0.734,
respectively). However, the results for cortical cataract were
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corrected p<0.017).
Investigation of the genotype frequencies both in patients
and controls revealed that there was a significant difference
between frequencies for SOD1-251GG genotype in patients
with cortical (22.3%) or mixed (26.2%) cataract and healthy
controls (13.7%). There was a significant difference between
frequencies  for  SOD1-251AA  genotype  in  patients  with
cortical  (33.1%)  or  mixed  (27.8%)  cataract  and  healthy
controls  (44.8%).  The  statistical  analysis  revealed  that
SOD1-251GG genotype may have a dangeous effect to the
development of cataract, and SOD1-251AA genotype may
have a protective effect against the development of cataract.
No  statistically  significant  difference  was  found  for  the
genotypic and allelic distributions of the polymorphisms in
CAT-21A/T, and GPX-198 C/T between controls and patients
even after stratifying by the cataract subtypes. Haplotypes
with frequencies are shown in Table 5. In age-related cataract
patients,  the  frequencies  of  AAC,  GAC  were  significant
differences than those of controls (p=0.002, p=0.016), and the
Figure 1. PCR analysis of SOD1 gene
polymorphism. One fragment of 570 bp
for  SOD1  wild-type  (AA),  two
fragments of 369 and 201 bp for variant
homozygous (GG); and three fragments
of  570,  369,  and  201  bp  for
heterozygous (AG). Columns show the
following:  M  column,  DL500  DNA
marker; 1 and 2 columns, SOD1 wild-
type  (AA);  3  and  7  columns,  SOD1
heterozygous (AG); 4, 5, and 6 columns,
SOD1 variant homozygous (GG).
TABLE 3. POLYMORPHISMS IN ANTIOXIDANT GENES SOD1-251A/G, CAT–21A/T, GPX–198 C/T, AND RISK OF CATARACT DEVELOPMENT.
Genotype Patients (%) Controls (%) OR (95% CI) p-value
SOD1–251A/G
AA 138 (33.3) 173 (44.8) 0.613 (0.461–0.817) 0.001
AG 191 (46.0) 160 (41.5) 1.204 (0.910–1.593) 0.200
GG 86 (20.7) 53 (13.7) 1.642 (1.129–2.389) 0.012
A allele frequency 0.563 0.655    
G allele frequency 0.437 0.345 1.479 (1.208–1.810) 0.001
CAT-21A/T
AA 204 (49.2) 207 (53.6) 0.836 (0.633–1.104) 0.229
AT 167 (40.2) 148 (38.3) 1.083 (0.815–1.438) 0.613
TT 44 (10.6) 31 (8.1) 1.358 (0.839–2.199) 0.226
A allele frequency 0.693 0.728    
T allele frequency 0.307 0.272 1.187 (0.956–1.474) 0.123
GPX-198 C/T
CC 201 (48.4) 208 (53.9) 0.804 (0.609–1.061) 0.137
CT 177 (42.7) 149 (38.6) 1.183 (0.892–1.569) 0.250
TT 37 (8.9) 29 (7.5) 1.205 (0.726–2.001) 0.521
C allele frequency 0.698 0.732    
T allele frequency 0.302 0.268 1.183 (0.952–1.471) 0.135
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2328frequencies of AAT, ATC, ATT, GTC, GAT, and GTT were
no  significant  differences  than  those  of  control  (p=0.94,
p=0.421,  p=0.698,  p=0.764,  p=0.607,  and  p=0.082,
respectively).
DISCUSSION
In this study, we analyzed the association between SOD1–
251A/G,  CAT–21A/T,  and  GPX1–198C/T  polymorphisms
with the risk of cataract in the Chinese population since these
polymorphisms  may  change  the  enzymes’  antioxidant
capacity and subsequently lead to synergistic effects with
cataract induced by oxidative damage. In our experiments, we
found  that  the  SOD1–251A/G  polymorphisms  were
associated with an increased risk of cataract, and we found no
statistically  significant  association  in  CAT–21A/T  and
GPX1–198C/T  polymorphisms  between  the  controls  and
patients. These findings support the hypothesis that genetic
variations  in  antioxidant  defense  may  modify  the  risk  of
cataract among individuals with increased oxidative stress or
decreased antioxidant capacity.
Defects in antioxidant pathways are connected to several
different types of diseases, including diabetes, age-related
diseases  and  cancer  [12,13,21].  Antioxidant  enzymes  can
catalytically remove free radicals and other reactive species.
Among the antioxidant enzymes, SOD is considered to be
important in the oxidant defense mechanism, as it is involved
in the first line of defense [4]. The SOD1 gene is located on
chromosome 21p22.11, an A/G sequence variant at codon 251
that has been studied most frequently [17,18]. The CAT gene
is located on chromosome 11p13.31 and contains 13 exons.
There is a common polymorphism in the promoter region of
the CAT gene consists of A to T at codon 21 [14,16]. The
GPX1  gene  is  located  on  chromosome  3p21.3.  Several
variants of GPX1 have been described, and one affecting
codon 198 that results in a C to T change has been studied
most  frequently  [18,19].  Previous  studies  examining  the
association between ROS and various diseases have revealed
that  excessive  oxidative  stress  or  decreased  antioxidant
activity can cause several pathologic states [12,13,21,22].
To  the  best  of  our  knowledge,  no  studies  have
investigated  the  role  of  antioxidant  gene  SOD1–251A/G,
CAT–21A/T, and GPX1–198C/T polymorphisms for patients
having  cataract.  Recent  studies  reported  important
associations  of  the  SOD1–251A/G  polymorphism  with  a
TABLE 4. DISTRIBUTION OF GENOTYPE FREQUENCIES OF SOD1-251A/G, CAT-21A/T, AND GPX-198 C/T POLYMORPHISMS IN CONTROLS AND
PATIENTS WITH DIFFERENT CATARACT SUBTYPES.
  Cataract subtypes
Genotype Control n (%) Cortical n (%)
n=121
Nuclear n (%)
n=109                         n=59
   PSCC n (%)       Mixed n (%)
n=126
SOD1–251A/G
AA 173 (44.8) 40 (33.1)a 41 (37.6) 22 (37.3) 35 (27.8)c
AG 160 (41.5) 54 (44.6) 51 (46.8) 28 (47.5) 58 (46.0)
GG 53 (13.7) 27 (22.3)b 17 (15.6) 9 (15.2) 33 (26.2)d
CAT-21A/T
AA 207 (53.6) 62 (51.2) 55 (50.5) 29 (49.2) 58 (46.0)
AT 148 (38.3) 47 (38.9) 43 (39.4) 23 (39.0) 54 (42.9)
TT 31 (8.1) 12 (9.9) 11 (10.1) 7 (11.8) 14 (11.1)
GPX-198 C/T
CC 208 (53.9) 61 (50.4) 52 (47.7) 29 (49.1) 59 (46.8)
CT 149 (38.6) 52 (43.0) 49 (45.0) 25 (42.4) 51 (40.5)
TT 29 (7.5) 8(6.6) 8 (7.3) 5 (8.5) 16 (12.7)
        PSCC, posterior subcapsular cataract. ap=0.026; OR: 0.608, 95% CI: 0.396–0.933. bp=0.031; OR: 1.805, 95% CI: 1.076–3.026.
            cp=0.001; OR: 0.474, 95% CI: 0.305–0.734. dp=0.002; OR: 2.229, 95% CI: 1.364–3.645.
TABLE 5. HAPLOTYPE FREQUENCIES OF SOD1-251A/G, CAT-21A/T, AND GPX-198 C/T IN CONTROLS AND PATIENTS.
SOD1–251 CAT-21 GPX-198 Frequency Patients Controls p-value OR (95% CI)
A A C 0.409 0.360 0.465 0.003 0.648 (0.488–0.860)
A A T 0.090 0.090 0.090 0.94 0.982 (0.605–1.593)
A T C 0.072 0.080 0.065 0.421 1.247 (0.728–2.139)
A T T 0.034 0.030 0.035 0.698 0.859 (0.399–1.852)
G A C 0.134 0.160 0.105 0.016 1.665 (1.095–2.532)
G A T 0.075 0.080 0.070 0.607 1.149 (0.677–1.949)
G T C 0.097 0.095 0.100 0.764 0.931 (0.583–1.485)
G T T 0.089 0.105 0.070 0.082 1.577 (0.956–2.602)
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2329reduced  antioxidant  capacity  [15,18].  SOD  is  the  major
enzyme to scavenge the superoxide radical in all eye tissues.
The studies of SOD activity in animal models and in humans
with cataract have reported varying levels of red blood cell
SOD  activity  in  patients  with  different  types  of  cataract.
Researchers have also found that the level of SOD activity to
be significantly lower in mature cataractous lenses than in
clear lenses [4,23,24].
The lens is often under the threat of oxidative stress. ROS-
mediated  oxidative  damage  has  been  shown  in  the
pathogenesis  of  cataract.  ROS  initiate  lipid  peroxidation
leading to increased production of lipid peroxides in various
forms of cataract. Mitochondrial production of superoxide
increases with age. Superoxide may diffuse throughout the
lens via the lens membranes. This process could contribute to
elevated H2O2 in the nucleus of older lenses [25]. In normal
conditions, LECs use several strategies to maintain ROS at
low levels to protect lipids, proteins, and nucleic acids. These
strategies include activation of the ROS scavenger enzymes
such as SOD, CAT, and GPX, and nonenzymatic scavengers
such as reduced GSH, ascorbate, cysteine, and vitamin E
[26]. However, these ROS scavengers diminish with aging,
placing the lens at risk for oxidative damage and cataract. A
‘‘vicious cycle’’ of decreased antioxidant activity and excess
of ROS production may be established within cells, which
may lead to a loss of the mitochondrial membrane potential,
DNA damage and the release of cytochrome c, resulting in
cell  apoptosis  and  death  [27,28].  The  increased  oxidative
damage,  decreased  capacity  of  antioxidant  enzymes,  and
apoptosis or death of LECs may cause a “vicious cycle” of
oxidative  stress  that  possibly  contributes  to  the  onset  of
cataract [24,29-31]. The SOD1 level was still represented
90%  of  the  SOD  activity  in  lens  [32].  In  this  study,  the
polymorphisms of SOD1–251A/G may diminish the capacity
to  scavenge  superoxide  radical  in  lens,  the  superfluous
radicals may contribute to the development of cataract.
Most studies have suggested that the polymorphisms of
CAT–21A/T  and  GPX1–198C/T  reduce  their  antioxidant
capacity,  these  genes  polymorphisms  are  risk  factor  for
different kinds of diseases [14,16,18,19]. CAT and GPX are
important components of cell defense against oxidative stress,
but we did not find any association between these enzymes’
polymorphisms with the risk of cataract in our study. We
propose  several  potential  explanations  for  the  lack  of  a
relationship between the two enzymes’ polymorphisms and
the  risk  of  cataract  in  our  study.  First,  cataract  is  a
multifactorial disease and the pathogenesis is complicated.
Specifically, it can be caused by exposure over time to a large
number of physiologic signals that come through aqueous
humor such as hydrogen peroxide, oxygen, and UV light,
producing  oxidative  damage  in  the  lenses  of  several
mammalian  species.  The  toxic  effects  of  the  ROS  are
generally  controlled  in  the  lens  and  aqueous  humor  by
antioxidant enzymes and nonenzymatic scavengers [33-36].
Second,  the  exposure  and  interaction  of  other  genes
participating in antioxidant recognition, repair and cell cycle
regulation  may  have  altered  the  effect  of  CAT  and  GPX
polymorphisms. Although multiple environmental factors are
involved in the pathogenesis of cataract, many studies also can
proved that genetic factors are also largely responsible for the
development of lens opacity [37-40]. Haplotypes are thought
to  carry  information  about  possibly  unobserved  causal
variants  in  the  region  [41].  In  the  frequencies  of  the
haplotypes,  GAC  were  higher  in  patients  compared  with
healthy controls, suggesting that this haplotype may increase
the risk of age-related cataract. Furthermore, we found the
haplotype  frequencies  of  AAC  were  lower  in  patients
compared with healthy controls. This result might imply a
protective role for this haplotype of AAC in combination of
age-related cataract in Chinese Han population.
In  conclusion,  this  report  is  the  first  to  suggest  an
association  between  the  polymorphisms  of  antioxidant
enzyme  genes  with  cataract  in  the  Chinese  population.
However, there is a need for other ethnicities and nationalities
to confirm our findings, and to fully examine the possible
relationship  between  antioxidant  enzyme  genes’
polymorphisms with cataract. These data emphasize that the
importance of antioxidant enzyme genes’ polymorphisms and
antioxidant enzymes as pharmacological targets to reduce
ROS production may provide a strategy to prevent or slow the
progression of age-related cataract formation.
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